Vivos Therapeutics Inc (VVOS)

Überblick Nachrichten Preisverlauf Financials Forum Prognose Aktiensplit

Finanzdaten der Vivos Therapeutics Inc-Aktie (VVOS)

*Alle Zahlen in Millionen

Enddatum des Zeitraums	2025-03-31	2024-06-30	2024-03-31	2023-12-31	2023-09-30
Periodenlänge	3 Monate	3 Monate	3 Monate	3 Monate	3 Monate
Revenues	25.60% 3.016	4.054	3.419	3.248	3.301
Cost Of Revenue	7.41% 1.507	1.403	0.10	-	0.10
Gross Profit	43.08% 1.509	2.651	1.937	1.938	1.898
Operating Expenses	18.31% 5.427	4.587	5.722	6.222	5.387
Benefits Costs and Expenses	14.97% 6.88	5.984	7.182	27.38	-
Costs And Expenses	14.97% 6.88	5.984	7.182	3.819	6.79
Depreciation and Amortization	22.07% 0.177	0.145	0.146	0.149	0.15
Operating Income/Loss	102.38% -3.918	-1.936	-3.785	-4.284	-3.489
Income/Loss From Continuing Operations Before Tax	100.21% -3.864	-1.93	-3.763	-24.14	3.301
Income/Loss From Continuing Operations After Tax	100.21% -3.864	-1.93	-3.763	-4.259	-2.093
Net Income/Loss	100.21% -3.864	-1.93	-3.763	-4.259	-2.093
Preferred Stock Dividends And Other Adjustments	-	-	-	-	-
Attributable To Noncontrolling Interest	-	-	-	-	-
Basic Average Shares	166.24% 8.5953	3.2284	2.3082	0.0668	1.1973
Diluted Average Shares	166.24% 8.5953	3.2284	2.3082	0.0668	1.1973
Basic Earnings Per Share	25.00% -0.45	-0.60	-1.63	-3.05	-1.75
Diluted Earnings Per Share	25.00% -0.45	-0.60	-1.63	-3.05	-1.75
Participating Securities, Distributed And Undistributed Earnings/Loss, Basic	-	-	-	-	-

PODD

$334.35

0.76%

STE

$248.98

0.16%

PHG

$27.69

0.43%

DXCM

$76.38

0.34%

GEHC

$74.26

0.23%

$80.90

0.46%